NCT07146555

Brief Summary

Investigator study aims to assess the level of vitamin D in adult patients with newly diagnosed ITP and correlation between its level and treatment respose

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for all trials

Timeline
18mo left

Started Sep 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Sep 2025Oct 2027

First Submitted

Initial submission to the registry

August 21, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 28, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

September 30, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2027

Last Updated

September 8, 2025

Status Verified

August 1, 2025

Enrollment Period

2 years

First QC Date

August 21, 2025

Last Update Submit

August 30, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Evaluation of Vitamin D Status in Adult Patients with Newly Diagnosed Immune Thrombocytopenia (ITP)

    Baseline to 3 months

Study Arms (3)

First group is responder to ttt of ITP

3 groups and assess vitamin D level and its relation with bleeding severity and treatment response

Other: No Interventions

Second group is non responder to ttt of ITP

Interventions

3 groups and assess vitamin D level and its relation with bleeding severity and treatment response

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (\>18 years), both male and female, with newly diagnosed immune thrombocytopenia (ITP), recruited from hematology clinics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood samples will be collected to assess vitamin D level

Central Study Contacts

Nourhan Hassan Mohammed Abdelrahiem M Mohamed Abdelrahiem

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident Doctor in internal Medicine Department at Assiut University hospitals

Study Record Dates

First Submitted

August 21, 2025

First Posted

August 28, 2025

Study Start

September 30, 2025

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

October 30, 2027

Last Updated

September 8, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share